Publication
Acute Myeloid Leukemia(AML) proteins for in silico drug design using pharmacophore modeling, molecular docking and molecular dynamics simulation.
Partho Bosu, Tonmoy Adhikary, Abu Sayed Rafi, Naveed Iqbal, Fatima Rasool, Payer Ahmed
PloS oneJan 1, 2026PMID 42685040doi:10.1371/journal.pone.0354456 PMC13537598Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 14, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260914-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Acute Myeloid Leukemia (AML) is a hematological malignancy characterized by abnormal myeloid cell differentiation, disrupting normal hematopoiesis. This study utilized an integrated computational approach to identify key molecular targets and potential inhibitors for AML therapy. Analysis of the…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerLeukemiadictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.